Allecra Therapeutics raised €15M in a Series A round in Apr 2015. The company is based in Weil am Rhein, Germany. Investors in the round: Edmond de Rothschild Venture Capital, EMBL Ventures. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €15M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
